Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/08/21 → 31/12/24 |
Keywords
- Pancreatic Ductal Adenocarcinoma (PDAC)
- Gastroenterology
- Pancreatic cancer
- Clinical trial
Clinical Trial Phase
- Phase I
A Phase I Study of PTM-101 as Neoadjuvant Therapy for Borderline Resectable or Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
- Pilgrim, Charles (Primary Chief Investigator (PCI))
- Nikfarjam, Mehrdad (Chief Investigator (CI))
- Hawkins, Cheryl-Ann (Project Manager)
Project: Research